1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Urology Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence and prevalence of urological conditions
5.1.1.2. Growing preference for minimally invasive procedures
5.1.1.3. Supportive government initiatives for urological treatment and diagnosis
5.1.2. Restraints
5.1.2.1. High cost associated with urological devices coupled with risk of product recall
5.1.3. Opportunities
5.1.3.1. Technological advancements in urology devices
5.1.3.2. Rise in the number of approvals for novel urology devices
5.1.4. Challenges
5.1.4.1. Technical limitations and limited availability of skilled urologists worldwide
5.2. Market Segmentation Analysis
5.2.1. Product: Significant penetration of urology endoscopes
5.2.2. Indication: Growing need of urology devices to diagnose and treat kidney diseases
5.2.3. End-User: Extensive use of urology devices by the hospitals & clinics
5.2.4. Application: Proliferating adoption of urology devices for diagnosis & monitoring of urological conditions
5.3. Market Trend Analysis
5.3.1. Significant emphasis on development of minimally invasive urology devices in the Americas
5.3.2. Prevalence of urological conditions and need for robust urology diagnostic and treatment devices in the APAC region
5.3.3. Growing awareness regarding urology conditions and improving accessibility of advanced urology devices in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Urology Devices Market, by Product
6.1. Introduction
6.2. Dialysis Devices
6.3.1. Hemodialysis
6.3.2. Peritoneal Dialysis
6.3. Laser Systems
6.4. Lithotripters
6.5. Robotic Surgical Systems
6.6. Urodynamic Systems
6.7. Urology Consumables
6.8.1. Catheters
6.8.2. Guidewires
6.8. Urology Endoscopes
7. Urology Devices Market, by Indication
7.1. Introduction
7.2. Benign Prostatic Hyperplasia
7.3. Kidney Diseases
7.4. Pelvic Organ Prolapse
7.5. Prostate Cancer
7.6. Urinary Stones
8. Urology Devices Market, by End-User
8.1. Introduction
8.2. Dialysis Centers
8.3. Hospitals & Clinics
9. Urology Devices Market, by Application
9.1. Introduction
9.2. Diagnosis & Monitoring
9.3. Treatment
10. Americas Urology Devices Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Urology Devices Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Urology Devices Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Laborie Medical Concludes Acquisition of Urotronic
13.3.1.2. Medical Device Maker Teleflex to Acquire Urology Company Palette Life Sciences for USD 600 Million
13.3.1.3. Olympus to Acquire Taewoong Medical: Strengthening its GI Endotherapy Portfolio for Improved Patient Outcomes
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. International Bladder Cancer Group (IBCG) and UroToday Announce Formal Partnership to Enhance Patient Outreach
13.3.2.2. Florida Urology Center Enters Into Partnership with US Urology Partners
13.3.2.3. Telix and Mauna Kea Technologies to Expand Collaboration in Urologic Oncology Surgery
13.3.2.4. CORONA Remedies Collaborates with Ferring Pharmaceuticals to Commercialize Maternal Health & Urology Products in India
13.3.3. New Product Launch & Enhancement
13.3.3.1. Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System
13.3.3.2. Cook Medical Launches Urological Bipolar Electrodes Portfolio
13.3.4. Investment & Funding
13.3.4.1. Gynesonics Secures USD 42.5 Million for Uterine Fibroids Device Expanded Rollout
13.3.4.2. Startup Minze Health Raises EUR 3.9 Million From Three Investors
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Medtronic Receives CE Mark for Hugo Robotic System
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Advanced MedTech Holdings Pte. Ltd.
14.1.2. Advin Health Care
14.1.3. Allium Medical Solutions Ltd.
14.1.4. Ambu A/S
14.1.5. Asahi Kasei Medical Co., Ltd.
14.1.6. B. Braun SE
14.1.7. Baxter International Inc.
14.1.8. Becton, Dickinson, and Company
14.1.9. BlueWind Medical, Ltd.
14.1.10. Boston Scientific Corporation
14.1.11. Cardinal Health, Inc.
14.1.12. Coloplast A/S
14.1.13. Cook Group Incorporated
14.1.14. Dialife SA
14.1.15. Dornier MedTech GmbH
14.1.16. Erbe Elektromedizin GmbH
14.1.17. Fresenius SE & Co. KGaA
14.1.18. GE HealthCare Technologies, Inc.
14.1.19. Gynesonics, Inc.
14.1.20. Hollister Incorporated
14.1.21. Intuitive Surgical, Inc.
14.1.22. Johnson & Johnson Services, Inc.
14.1.23. KARL STORZ SE & Co. KG
14.1.24. Laborie Medical Technologies, Inc.
14.1.25. McKesson Medical-Surgical Inc.
14.1.26. Medline Industries, LP
14.1.27. Medtronic PLC
14.1.28. Nipro Medical Corporation
14.1.29. Olympus Corporation
14.1.30. Precision Optics Corporation
14.1.31. Richard Wolf GmbH
14.1.32. Rockwell Medical Inc.
14.1.33. Siemens Healthcare GmbH
14.1.34. SonoMotion
14.1.35. Stryker Corporation
14.1.36. Teleflex Incorporated
14.1.37. Terumo Corporation
14.1.38. Virtuoso Surgical, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer